scispace - formally typeset
J

Javier P. Gisbert

Researcher at Autonomous University of Madrid

Publications -  1076
Citations -  39753

Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.

Papers
More filters
Journal ArticleDOI

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

Adrian G. McNicholl, +23 more
- 01 May 2013 - 
Journal ArticleDOI

409 Adalimumab for Ulcerative Colitis Patients Previously Treated With Infliximab: Outcomes at Short and Long Term and Predictors of Response

Carlos Taxonera, +13 more
- 01 May 2010 - 
Journal ArticleDOI

Amoxicillin Gastric Retention Systems for Helicobacter pylori Treatment

Javier P. Gisbert, +4 more
- 01 May 2011 - 
Journal ArticleDOI

S1175 Immune Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease

María Chaparro, +3 more
- 01 May 2010 - 
TL;DR: The results demonstrate the first correlate that could have functional significance between epigenetic modification at the level of IFNG DNA, immune response to microbial components, and expression of IFN-γ in UC patients.
Journal ArticleDOI

Su1165 Meta-Analysis of Sequential vs. Standard Triple Therapy for Helicobacter pylori Eradication: Final Results of a Cochrane Systematic Review

Olga P Nyssen, +8 more
- 01 May 2014 - 
TL;DR: Japanese is below Westerners in the ratio of homo-EM as well as RPZ based triple therapy without relation to CYP2C19 genotype, in Japan, and there was negative effect on eradication rates.